The editorial team

Visit Korea Medical does not publish under single-author bylines. Coverage on this site is produced by a contributing-editor team operating under an editorial board, with named bylines on our specialised publisher archives and a shared institutional byline — the Visit Korea Medical Editorial Team — on the central directory site. The model is deliberate. International medical-tourism coverage is a long-running, multi-platform, multi-cluster subject, and the conventional single-author travel-writer model does not align with the actual expertise pattern of the Korean aesthetic-medicine market. Our contributing editors operate inside specialised lanes — platforms (microfocused ultrasound, radiofrequency, regenerative medicine), clusters (Gangnam, Apgujeong-Cheongdam, Myeongdong, regional cities), and visitor-logistics areas (visa, transit, aftercare) — and coverage is assigned by lane rather than by name. This page describes the model in detail and is the canonical author profile for editorial pages on the central site.

Why the contributing-editor model

The choice of an institutional byline rather than a single-author byline reflects three editorial considerations. First, the Korean aesthetic-medicine market is a moving target: platform generations turn over every two to four years, the senior-physician landscape shifts as flagship practices open and consolidate, and treatment-pricing context changes quarterly. Single-author coverage of a moving target tends either to age badly (the author has moved on) or to consolidate around a few high-profile practices that no longer represent the market accurately. A contributing-editor team rotating coverage by lane is structurally better suited to refreshing context. Second, comparative coverage — the work of telling a visitor which cluster, which platform, which trip frame is right for them — requires multiple specialised perspectives rather than one generalist voice. Third, our editorial standards forbid both numerical rankings and headline-form named-physician endorsement; a contributing-editor model with editorial board review enforces that discipline more reliably than a single-author byline would.

The editorial board

The Visit Korea Medical editorial board is a four-member institutional body that signs off on coverage scope, comparative-coverage standards, and corrections. Board membership is constituted from senior contributing editors across the platform, cluster, and visitor-logistics lanes plus a managing editor responsible for compliance with Article 56 (4) of the Korean Medical Service Act. Board members are not anonymous to KHIDI or to our legal advisers but are not individually credited on coverage pages, in line with the contributing-editor model described above. The board reviews this editorial-policy framework quarterly and is responsible for handling conflict-of-interest recusals, right-of-reply submissions on critical coverage, and the structural decision-making that shapes coverage scope (which platforms, which clusters, which regional cities receive editorial allocation in any given quarter). Board decisions on coverage scope are documented in an internal record available to KHIDI on request.

Contributing editors and the lane structure

Contributing editors operate inside named editorial lanes. Platform lanes include microfocused ultrasound (Ultherapy, Sofwave), radiofrequency (Thermage FLX, Genius RF, Secret RF), regenerative medicine (exosomes, growth factors, stem-cell-derived protocols), thread lifting, injectables, and laser. Cluster lanes follow the [Seoul medical district map](/cities/seoul-medical-district-map/) — Gangnam Station, Apgujeong-Rodeo, Cheongdam-dong, Myeongdong — plus regional cluster lanes for Busan, Incheon, and Jeju. Visitor-logistics lanes cover visa, transit, hotels, aftercare, post-procedure flying rules, and insurance. Editors are assigned coverage inside their lane based on expertise rather than on availability, and cross-lane coverage (a platform piece that also touches a cluster, for example) is jointly bylined inside the team rather than handed to a generalist. Bylines on our specialised publisher archives are named; bylines on the central directory are institutional.

Coverage workflow — how a page reaches publication

Every editorial page on Visit Korea Medical passes through a four-step workflow. First, lane assignment: the managing editor allocates the coverage brief to the relevant lane editor with a defined scope (the platform, the cluster, the visitor question). Second, research and drafting: the lane editor produces a draft against the sourcing standards described on our [editorial policy page](/editorial-policy/) — public clinic price lists for pricing context, manufacturer authorised-provider directories for platform context, KHIDI annual statistics for cluster context, and primary-source verification for any clinic-level entries. Third, peer review: a second contributing editor in an adjacent lane reads the draft for cross-lane accuracy and for compliance with our comparative-coverage standards (no numerical rankings, no headline-form named-physician endorsement, no patient testimonials with named outcomes). Fourth, board sign-off: the managing editor signs the page off against the Article 56 (4) compliance checklist before publication. The whole workflow typically runs five to twelve working days per major editorial piece.

Conflicts of interest and recusal

Contributing editors who hold a personal financial interest in any covered clinic — direct equity, paid advisory, family relationship, prior employment of less than three years standing — recuse themselves from coverage decisions on that clinic. The recusal is logged internally and is available to KHIDI on request, in line with the conflict-of-interest framework described on our [editorial policy page](/editorial-policy/). Where a contributing editor's lane includes a clinic in which they hold a recusable interest, an editor from an adjacent lane covers that clinic instead, with the original lane editor not participating in the editorial discussion. The contributing-editor model carries an inherent advantage for conflict-of-interest management: lane redundancy allows clean substitution without leaving coverage gaps. Some outbound links on this site are commercial referrals carrying the rel="sponsored noopener" attribute; editorial inclusion is independent of those commercial relationships.

Corrections, right of reply, and how to reach us

Errors of fact are corrected as soon as they are flagged. The correction is logged on the page, with the date the error was identified and the date corrected, in line with the standards on our [editorial policy page](/editorial-policy/). Right-of-reply submissions on critical coverage are read and, where the underlying claim is in dispute, are added as a quoted response on the page rather than overwriting the original copy. Clinics that wish to update operational details — opening hours, language coverage, platform availability — can email [email protected] with primary-source documentation. The board does not commit to a response window on general correspondence, but factual-correction submissions are typically acknowledged within five working days. Visitors with broader questions about a trip frame are better served by the relevant cluster or platform editorial page; we do not act as a booking concierge through editorial channels.

“On the central directory the editorial board, not the individual draft, is the unit of editorial responsibility — that is what the institutional byline reflects.”

Visit Korea Medical editorial board

Frequently asked questions

Are the editorial team members real people?

Yes. The contributing editors and board members are real people whose identities are available to KHIDI and to our legal advisers. They are not named on the public byline of central directory pages because the editorial-board model treats the board, not the individual draft, as the unit of editorial responsibility. Named bylines appear on our specialised publisher archives.

Why does Visit Korea Medical not publish single-author bylines?

The Korean aesthetic-medicine market is a moving target across platforms, clusters, and pricing context. A contributing-editor team rotating coverage by specialised lane is structurally better suited to refreshing that context than a single-author byline would be. The institutional byline also enforces editorial-standards discipline (no numerical rankings, no headline-form named-physician endorsement) more reliably.

How is coverage assigned?

By lane and by expertise rather than by name. The managing editor allocates each coverage brief to the relevant lane editor — platform, cluster, or visitor logistics — with a defined scope. Cross-lane coverage is jointly handled inside the team. Editors with a recusable interest in a covered clinic are substituted by an editor from an adjacent lane.

Who signs the page off?

The managing editor signs every editorial page off against the Article 56 (4) compliance checklist before publication. Peer review by a second contributing editor in an adjacent lane happens before sign-off. The whole workflow typically runs five to twelve working days per major editorial piece.

How do I correct an error or submit a right of reply?

Email [email protected] with the URL of the page, the specific claim in dispute, and primary-source documentation. Corrections are logged on the page with the date identified and the date corrected. Right-of-reply submissions on critical coverage are added as a quoted response rather than overwriting the original copy.

Do contributing editors hold financial interests in covered clinics?

Contributing editors with personal financial interests in a covered clinic — direct equity, paid advisory, family relationship, prior employment of less than three years standing — recuse themselves from coverage of that clinic. The recusal log is maintained internally and is available to KHIDI on request. Adjacent-lane editors handle the substitution coverage.

Are bylines on the specialised publisher archives different?

Yes. Specialised publisher archives covering a single platform or a single cluster carry named contributing-editor bylines on individual pieces. The central directory carries the institutional Visit Korea Medical Editorial Team byline. Both byline tiers operate under the same editorial-standards and conflict-of-interest framework; the difference is the unit of editorial responsibility (board on the central directory, individual editor on specialised archives).